ROCHESTER, Minn. — Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a study published today in the New England Journal of Medicine. Journalists: Sounds bites with Dr. Tefferi are available in the download. "We observed that Imetelstat was active and induced morphologic […]
A recent commentary published in the New England Journal of Medicine (NEJM) by Philip J. Landrigan and Charles Benbrook has sparked some controversy. Landrigan and Benbrook are publishing in a medical journal because they claim the issue of genetically modified organisms (GMOs) is a public health issue. They use extremely strained logic and misrepresentation to [...]
There’s a piece in the New England Journal of Medicine written by Aaron Belkin, Ph.D. entitled Caring for Our Transgender Troops — The Negligible Cost of Transition-Related Care to convince Defense Secretary Ashton Carter to lift the ban on transgender military personnel. Doctor Belkin, Ph.D says that the military can easily afford to allow transgender […]
Health care has much to learn from innovative high-tech companies, but not in the way most people think, according to a Perspective published today in the New England Journal of Medicine and authored by innovation experts from the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. Show More Summary
The New England Journal of Medicine, the most important medical periodical in the world, has a few bones to pick with the Republican Party’s would-be presidential candidates. In an editorial, the journals’ editors attack the stance held by most of the Republican hopefuls that Planned Parenthood should be defunded. A separate opinion piece argues that there is nothing wrong […]
Research coordinated by the ECOG-ACRIN Cancer Research Group and just published in the The New England Journal of Medicine, examines the outcomes of giving the chemotherapy drug docetaxel at the start of androgen deprivation therapy for patients with metastatic hormone-sensitive prostate cancer. Show More Summary
A new review article, published in the July 23, 2015 issue of The New England Journal of Medicine, analyzes the pros and cons of five different interventional approaches to gallbladder disease.
Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.
Source: Chronicle Augusta.com Mike Magee This week, Ted Kaptchuk and Franklin Miller published a seminal article in the New England Journal of Medicine titled, “Placebo Effects in Medicine”. I believe it will be remembered for many years,...Show More Summary
A study in the New England Journal of Medicine reports that taking daily shots of liraglutide (marketed as Saxenda) can help overweight or obese patients lose weight -- a lot of it. Patients taking the medication lost an average of more than 12 pounds, twice as much as those on a placebo, after 56 weeks.Read full article >>
The "placebo effect" is often described as events that occur when patients show improvement from treatments that contain no active ingredients. A "Perspectives" article in the July 2 issue of The New England Journal of Medicine proposes that placebo effects be more broadly defined to reflect their role as a valuable component of medical care.
As we recently discussed (here, here, here and here), in May, 2015, the New England Journal of Medicine, arguably the world's foremost medical journal, published an editorial and a three-part commentary arguing that current concerns about the effects of financial conflicts of interest (COI) on health care are overblown(1-4). Show More Summary
Monte Shaheen, MD, and colleagues from around the country recently published a paper in the New England Journal of Medicine about a promising new treatment for melanoma.
A new take on TPP, which appears in the New England Journal of Medicine, gives me another reason to give the TPP a thumbs down.
There's a great study published today in the New England Journal of Medicine on a program for teaching college women how to behave in order to lower their risk of being sexually assaulted. The women who were assigned to take the four-part, small group training sessions were half as likely to [...]
The New England Journal of Medicine (NEJM) called the question: Has criticism of the pharmaceutical industry, and of physician relationships with that industry, gone too far? Are self-righteous “pharmascolds” blocking the kind of essential collaboration that brought streptomycin and other lifesaving treatments to market? The editorial by Dr. Show More Summary
Like a certain late lamented parrot, CardioExchange is no more. It has ceased to be. The website was started by the New England Journal of Medicine and the Massachusetts Medical Society more than 5 years ago in the wake of the explosive and ubiquitous growth of social media. But the rise of social media also provoked tremendous uncertainty and [...]
A group of former senior editors criticize a 'seriously flawed and inflammatory attack' by The New England Journal of Medicine on what that journal believes have become overly stringent policies on conflicts of interest.
A new report recently published in the New England Journal of Medicine shows a downward trajectory in severe mental health issues for children between the ages of 6 and 17. On the surface, this is good news. Yet on the flip side, the...Show More Summary